CG3 Consulting

In the past, organs exposed to hepatitis C were typically discarded or given only to patients who already had the illness. Using them in patients who don’t have the virus could shorten the transplant wait time for hundreds of patients each year.

The oversubscribed round comes just four months after acquisition of GSK’s gene therapy portfolio.

Dr. Gianrico Farrugia, the current chief of Mayo Clinic in Florida, will succeed Dr. John Noseworthy as CEO of the Rochester, Minnesota health system when he steps down at the end of this year.

Rep. Chris Collins of New York was arrested last week for insider trading in shares of Australia’s Innate Immunotherapeutics.

Erik Pupo, the newly minted CIO of Columbia University Irving Medical Center in New York City, spoke about his goals at the medical center as well as why simply throwing technology at a healthcare issue won’t solve the problem.

New research of more than 800 clinicians found those who knew about a patient’s overdose death cut the overall volume of opioids they prescribed by almost 10 percent over three months.

The drug is the first approved treatment for the condition, as well as the first siRNA drug to win the agency’s approval.

Seema Verma, administrator of the Centers for Medicare & Medicaid Services, said it’s wrong to have ACOs that can only make profits but not risk any losses. “We want to put the accountability back into Accountable Care Organizations,” she sa…